AGENUS INC
Public company- Headquarters
- LEXINGTON, Massachusetts
- Industry
- Biotechnology
- Ticker
- AGEN
- CIK
- 0001098972
WARN notices since 2024
0
None on record
Workers affected since 2024
0
Across 0 notices
Executive changes, last 12 months
1
1 appointment, 0 departures
Last event
Aug 11, 2026
Executive appointmentClass II director appointed: Marco Tullio Marcucci
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| Class II directorMarco Tullio Marcucci | Aug 11, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- Eloxx Pharmaceuticals, Inc.
director appointed: Geno J. Germano
- Voyager Therapeutics, Inc.
president appointed: Robin Swartz
- TScan Therapeutics, Inc.
Director departs: Garry Nicholson
- Moderna, Inc.
COO appointed: Juan Andres
- Executive appointment
Class II director appointed: Marco Tullio Marcucci
Marco Tullio Marcucci was named Class II director of AGENUS INC, effective August 5, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Aug 11, 2026Role: Class II director
Only one public record so far. We add events as soon as a new filing lands; watch AGENUS INC to get them in your digest.
Last verified Nov 8, 2026